Jane Street’s Oramed Pharmaceuticals ORMP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$95.3K Sell
42,367
-24,806
-37% -$55.8K ﹤0.01% 4983
2025
Q1
$144K Buy
67,173
+17,510
+35% +$37.5K ﹤0.01% 5100
2024
Q4
$120K Sell
49,663
-8,637
-15% -$20.9K ﹤0.01% 5279
2024
Q3
$142K Buy
58,300
+2,230
+4% +$5.44K ﹤0.01% 5369
2024
Q2
$144K Sell
56,070
-30,354
-35% -$78K ﹤0.01% 5529
2024
Q1
$252K Sell
86,424
-9,094
-10% -$26.6K ﹤0.01% 4803
2023
Q4
$221K Buy
95,518
+84,606
+775% +$195K ﹤0.01% 4922
2023
Q3
$28.5K Sell
10,912
-28,613
-72% -$74.7K ﹤0.01% 4841
2023
Q2
$142K Sell
39,525
-1,380
-3% -$4.94K ﹤0.01% 4692
2023
Q1
$89.2K Sell
40,905
-92,088
-69% -$201K ﹤0.01% 4990
2022
Q4
$1.6M Buy
132,993
+91,008
+217% +$1.09M ﹤0.01% 2183
2022
Q3
$272K Sell
41,985
-31,429
-43% -$204K ﹤0.01% 4305
2022
Q2
$336K Buy
73,414
+43,595
+146% +$200K ﹤0.01% 3978
2022
Q1
$258K Sell
29,819
-31,421
-51% -$272K ﹤0.01% 4445
2021
Q4
$875K Buy
61,240
+7,930
+15% +$113K ﹤0.01% 2875
2021
Q3
$1.17M Buy
53,310
+35,499
+199% +$780K ﹤0.01% 2471
2021
Q2
$238K Buy
+17,811
New +$238K ﹤0.01% 4262
2021
Q1
Sell
-20,291
Closed -$86K 5265
2020
Q4
$86K Sell
20,291
-12,444
-38% -$52.7K ﹤0.01% 3670
2020
Q3
$85K Buy
32,735
+12,193
+59% +$31.7K ﹤0.01% 3472
2020
Q2
$73K Buy
+20,542
New +$73K ﹤0.01% 3719
2020
Q1
Sell
-38,067
Closed -$196K 3800
2019
Q4
$196K Buy
38,067
+14,982
+65% +$77.1K ﹤0.01% 3008
2019
Q3
$74K Sell
23,085
-20,127
-47% -$64.5K ﹤0.01% 3215
2019
Q2
$155K Buy
+43,212
New +$155K ﹤0.01% 3186
2014
Q2
Sell
-14,948
Closed -$176K 2662
2014
Q1
$176K Buy
+14,948
New +$176K ﹤0.01% 2124